CEVEC Pharmaceuticals

About:

CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.

Website: http://www.cevec.com

Twitter/X: cevec1

Top Investors: NRW.BANK, Creathor Ventures, Peppermint Venture Partners, ERP Startfonds

Description:

CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system. CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.